Minn. R. agency 144, ch. 4615, METABOLIC DEFECT TESTING, TREATMENT, AND REGISTRY, pt. 4615.0760

Current through Register Vol. 49, No. 24, December 9, 2024

Part 4615.0760 - RESPONSIBILITIES OF DEPARTMENT OF HEALTH

Subpart 1.Treatment control test specimen kits.

The department shall develop and make available treatment control test specimen kits to physicians and patients as medically indicated to effectively monitor treatment, and provide the treatment control test specimen kit and the laboratory evaluation of the treatment control test specimen at no cost to the patient.

Subp. 2.Reporting of test results.

The department shall report the laboratory results of the treatment control tests to the physician or patient submitting the treatment control test specimen. If the treatment control test specimen is submitted directly by the patient, the patient shall identify a physician who shall receive a copy of the laboratory results.

Subp. 3.Assistance in obtaining treatment.

The department shall make arrangements for the medically indicated treatment of the metabolic defect in diagnosed cases of hemoglobinopathy, phenylketonuria, galactosemia, hypothyroidism, and/or congenital adrenal hyperplasia when the patient is uninsured or is unable to pay the cost of treatment because of a lack of available income. The arrangements include referral to appropriate agencies which have financial resources to pay for medically indicated treatment such as private health insurance companies, medical assistance, MinnesotaCare, and Services for Children with Disabilities.

Subp. 4.Registry of cases.

The department shall maintain a registry of all diagnosed cases of hemoglobinopathy, phenylketonuria, galactosemia, hypothyroidism, and congenital adrenal hyperplasia reported to the department. The registry shall be updated not more often than annually by direct contact with the patient to determine their address and their need for medical treatment services, educational materials, and counseling related to their metabolic disease. The registry shall include the following minimum data on each patient:

A. name of patient;

B. gender;

C. date of birth;

D. place of birth;

E. parents' names;

F. current address of patient;

G. diagnosis;

H. name and address of physician; and

I. other data the commissioner deems necessary for follow-up services.

Subp. 5.Classification of data.

The department shall treat all data in the registry as private pursuant to Minnesota Statutes, section 13.3805, the Minnesota Government Data Practices Act.

Minn. R. agency 144, ch. 4615, METABOLIC DEFECT TESTING, TREATMENT, AND REGISTRY, pt. 4615.0760

10 SR 2290; 17 SR 1758; L 1995 c 234 art 8 s 56; L 1999 c 227 s 22; L 2005 c 56 s 2

Statutory Authority: MS s 144.125; 144.128